Brainsway Ltd ADR (BWAY)

$15.89 +0.01 (0.06%)
Market Cap 623.04M
Revenue (ttm) 52.23M
Net Income (ttm) 7.58M
EPS (ttm) N/A
PE Ratio 45.40
Forward PE 52.38
Profit Margin 14.51%
Debt to Equity Ratio 0.00
Volume 68,236
Avg Vol 156,160
Day's Range N/A - N/A
Shares Out 40.04M
Stochastic %K 84%
Beta 1.23
Analysts Strong Sell
Price Target $16.67

Company Profile

BrainsWay Ltd. develops and sells noninvasive neurostimulation treatments for mental health disorders in the United States, East Asia, and internationally. It offers Deep Transcranial Magnetic Stimulation platform technology for the treatment of major depressive disorders, anxious depression, obsessive-compulsive disorders, smoking addiction, bipolar disorders, post traumatic stress disorders, schizophrenia, Alzheimer's disease, autism, chronic pain, multiple sclerosis, post stroke rehabilitatio...

Industry: Medical Devices
Sector: Healthcare
Phone: 972 2 582 4030
Address:
16 Hartum St, Har Hotzvim, Jerusalem, Israel
DARKP00L
DARKP00L May. 26 at 11:26 AM
$BWAY 06:41 on May. 26 2026 HC Wainwright & Co. Maintains Buy on BrainsWay, Raises Price Target to $17 #tradeideas
0 · Reply
Estimize
Estimize May. 14 at 10:03 AM
Wall St is expecting 0.04 EPS for $BWAY Q2 [Reporting 08/12 BMO] http://www.estimize.com/intro/bway?chart=historical&metric_name=eps&utm_co
0 · Reply
MarketBeat
MarketBeat May. 13 at 2:07 PM
https://marketbeat.com/a/8652620/ $BWAY Brainsway Q1 Earnings Call Highlights
0 · Reply
EarningsInsider
EarningsInsider May. 13 at 1:31 PM
https://www.marketbeat.com/earnings/reports/2026-5-13-brainsway-ltd-stock/ $BWAY Brainsway Earnings Transcript
0 · Reply
DARKP00L
DARKP00L May. 13 at 12:03 PM
$BWAY 07:34 on May. 13 2026 BrainsWay Affirms FY2026 Sales Guidance of $66.000M-$68.000M vs $66.350M Est #tradeideas
0 · Reply
StocktwitsEarnings
StocktwitsEarnings May. 13 at 11:38 AM
$BWAY Q1 '26 Earnings Results & Recap • Reported GAAP EPS of $0.06 up 100.00% YoY • Reported revenue of $15.53M up 34.63% YoY • BrainsWay reiterates full-year 2026 revenue guidance of $66M to $68M, targeting operating income of 13%-14% and Adjusted EBITDA of $12M to $14M, representing significant growth over 2025.
0 · Reply
SuperGreenToday
SuperGreenToday May. 12 at 7:50 PM
$BWAY Share Price: $16.79 Contract Selected: Oct 16, 2026 $20 Calls Buy Zone: $0.04 – $0.05 Target Zone: $0.07 – $0.09 Potential Upside: 60% ROI Time to Expiration: 156 Days | Updates via https://fxcapta.com/stockinfo/
0 · Reply
evparty
evparty May. 12 at 7:41 PM
$BWAY ISRAELI 🇮🇱MEDICAL DEVICE COMPANY CLINICS ADMINISTERING THIS ARE MAKING MONEY HAND OVER FIST EARNINGS TOMORROW PREMARKET 💰💰💰💰 $TSLA $WEN $SPY
0 · Reply
Blahblahstock25
Blahblahstock25 Apr. 24 at 7:31 PM
$BWAY https://www.marketbeat.com/instant-alerts/brainsway-nasdaqbway-sets-new-12-month-high-should-you-buy-2026-04-24/ The literally make a machine that cures depression. This will only go up for the foreseeable future
0 · Reply
moonlife224
moonlife224 Apr. 16 at 7:56 PM
$AEHL $BWAY $SPRC $TR
0 · Reply
Latest News on BWAY
Brainsway price target raised to $17 from $15 at H.C. Wainwright

2026-05-26T10:16:13.000Z - 3 days ago

Brainsway price target raised to $17 from $15 at H.C. Wainwright

BrainsWay (BWAY) Secures Strategic Financing Agreement for Growth

2026-05-18T13:27:40.000Z - 11 days ago

BrainsWay (BWAY) Secures Strategic Financing Agreement for Growth

Brainsway announces $1.5M investment in APS Innovations

2026-05-18T11:48:34.000Z - 11 days ago

Brainsway announces $1.5M investment in APS Innovations

BWAY

BrainsWay Announces Minority-Stake Investment in Hopemark Health

May 18, 2026, 7:30 AM EDT - 11 days ago

BrainsWay Announces Minority-Stake Investment in Hopemark Health

BWAY

BrainsWay Falls Short on Q1 2026: $0.06 EPS vs $0.17 Expected

2026-05-13T15:25:05.000Z - 16 days ago

BrainsWay Falls Short on Q1 2026: $0.06 EPS vs $0.17 Expected

Brainsway Q1 Earnings Call Highlights

May 13, 2026, 10:08 AM EDT - 16 days ago

Brainsway Q1 Earnings Call Highlights

BWAY

BrainsWay (BWAY) Reports Strong Q1 Growth and Adjusted EBITDA Forecast

2026-05-13T13:40:03.000Z - 16 days ago

BrainsWay (BWAY) Reports Strong Q1 Growth and Adjusted EBITDA Forecast

BrainsWay (BWAY) Reports Strong Q1 Revenue Growth

2026-05-13T13:39:08.000Z - 16 days ago

BrainsWay (BWAY) Reports Strong Q1 Revenue Growth

BrainsWay (BWAY) Reports Q1 Earnings with Strong Revenue Growth

2026-05-13T13:16:20.000Z - 16 days ago

BrainsWay (BWAY) Reports Q1 Earnings with Strong Revenue Growth

BrainsWay Earnings Call Transcript: Q1 2026

May 13, 2026, 8:30 AM EDT - 16 days ago

BrainsWay Earnings Call Transcript: Q1 2026

BrainsWay Earnings release: Q1 2026

May 13, 2026, 8:30 AM EDT - 16 days ago

BrainsWay Earnings release: Q1 2026

Brainsway reports Q1 EPS 6c, consensus 5c

2026-05-13T12:02:25.000Z - 16 days ago

Brainsway reports Q1 EPS 6c, consensus 5c

BWAY

Brainsway backs FY26 revenue view $66M-$68M, consensus $66.44M

2026-05-13T12:01:50.000Z - 16 days ago

Brainsway backs FY26 revenue view $66M-$68M, consensus $66.44M

BWAY

BrainsWay Reports First Quarter 2026 Financial Results and Operational Highlights

May 13, 2026, 7:30 AM EDT - 16 days ago

BrainsWay Reports First Quarter 2026 Financial Results and Operational Highlights

BWAY

BrainsWay Slides: Investor presentation

May 13, 2026, 7:00 AM EDT - 16 days ago

BrainsWay Slides: Investor presentation

BrainsWay to Report First Quarter 2026 Financial Results on May 13, 2026

Apr 29, 2026, 8:00 AM EDT - 4 weeks ago

BrainsWay to Report First Quarter 2026 Financial Results on May 13, 2026

BWAY

Zacks Industry Outlook Highlights Phibro Animal Health, BioLife Solutions, Omeros and Brainsway

2026-04-28T14:42:00.000Z - 4 weeks ago

Zacks Industry Outlook Highlights Phibro Animal Health, BioLife Solutions, Omeros and Brainsway

BrainsWay Highlights Growing U.S. Payer Support for Nurse Practitioner-Administered Transcranial Magnetic Stimulation (TMS) Therapy

Apr 15, 2026, 7:30 AM EDT - 6 weeks ago

BrainsWay Highlights Growing U.S. Payer Support for Nurse Practitioner-Administered Transcranial Magnetic Stimulation (TMS) Therapy

BWAY

BrainsWay to Participate in the 25th Annual Needham Virtual Healthcare Conference

Apr 13, 2026, 8:00 AM EDT - 6 weeks ago

BrainsWay to Participate in the 25th Annual Needham Virtual Healthcare Conference

BWAY

Brainsway completes revenue-based milestone investment into Axis Integrated

2026-03-19T12:00:50.000Z - 2 months ago

Brainsway completes revenue-based milestone investment into Axis Integrated

BWAY

BrainsWay Completes Revenue-Based Milestone Investment into Axis Integrated Mental Health

Mar 19, 2026, 7:30 AM EDT - 2 months ago

BrainsWay Completes Revenue-Based Milestone Investment into Axis Integrated Mental Health

BWAY

BrainsWay Slides: Investor presentation

Mar 18, 2026, 8:00 AM EDT - 2 months ago

BrainsWay Slides: Investor presentation

Brainsway price target adjusted to $15 at H.C. Wainwright after ADS ratio change

2026-03-12T12:20:51.000Z - 2 months ago

Brainsway price target adjusted to $15 at H.C. Wainwright after ADS ratio change

BWAY

BrainsWay Earnings Call Transcript: Q4 2025

Mar 11, 2026, 8:30 AM EDT - 2 months ago

BrainsWay Earnings Call Transcript: Q4 2025

BrainsWay Earnings release: Q4 2025

Mar 11, 2026, 8:30 AM EDT - 2 months ago

BrainsWay Earnings release: Q4 2025

BrainsWay Annual report: Q4 2025

Mar 11, 2026, 8:30 AM EDT - 2 months ago

BrainsWay Annual report: Q4 2025

Brainsway reports Q4 EPS 7c, consensus 3c

2026-03-11T11:38:13.000Z - 2 months ago

Brainsway reports Q4 EPS 7c, consensus 3c

BWAY

Brainsway sees FY26 revenue $66M-$68M, consensus $64.79M

2026-03-11T11:37:56.000Z - 2 months ago

Brainsway sees FY26 revenue $66M-$68M, consensus $64.79M

BWAY

BrainsWay Reports Fourth Quarter and Full Year 2025 Financial Results and Operational Highlights

Mar 11, 2026, 7:30 AM EDT - 2 months ago

BrainsWay Reports Fourth Quarter and Full Year 2025 Financial Results and Operational Highlights

BWAY

Brainsway announces new data on noninvasive way to treat depression

2026-03-04T12:50:32.000Z - 3 months ago

Brainsway announces new data on noninvasive way to treat depression

BWAY

Landmark Data Validate BrainsWay's SWIFT™ Deep TMS, Beginning a New Era in Depression Treatment

Mar 4, 2026, 7:30 AM EST - 3 months ago

Landmark Data Validate BrainsWay's SWIFT™ Deep TMS, Beginning a New Era in Depression Treatment

BWAY

BrainsWay to Report Fourth Quarter and Full Year 2025 Financial Results on March 11, 2026

Feb 25, 2026, 8:00 AM EST - 3 months ago

BrainsWay to Report Fourth Quarter and Full Year 2025 Financial Results on March 11, 2026

BWAY

Brainsway announces new minority-stake investment in BrainStim Health

2026-02-19T12:40:17.000Z - 3 months ago

Brainsway announces new minority-stake investment in BrainStim Health

BWAY

BrainsWay Announces New Minority-Stake Investment in Canadian Provider, BrainStim Health Inc.

Feb 19, 2026, 7:30 AM EST - 3 months ago

BrainsWay Announces New Minority-Stake Investment in Canadian Provider, BrainStim Health Inc.

BWAY

Brainsway says Cigna’s Evernorth to eliminate authorization requirement for TMS

2026-02-18T12:35:26.000Z - 3 months ago

Brainsway says Cigna’s Evernorth to eliminate authorization requirement for TMS

BWAY CI

BrainsWay Reports Cigna's Evernorth Behavioral Health to Eliminate Prior Authorization Requirements for TMS Coverage, Accelerating Access to Care

Feb 18, 2026, 7:30 AM EST - 3 months ago

BrainsWay Reports Cigna's Evernorth Behavioral Health to Eliminate Prior Authorization Requirements for TMS Coverage, Accelerating Access to Care

BWAY

Brainsway announces change in ADS-to-ordinary share ratio

2026-02-17T12:45:55.000Z - 3 months ago

Brainsway announces change in ADS-to-ordinary share ratio

BrainsWay Announces Change in ADS-to-Ordinary Share Ratio

Feb 17, 2026, 7:30 AM EST - 3 months ago

BrainsWay Announces Change in ADS-to-Ordinary Share Ratio

Brainsway management to meet virtually with Northland

2026-02-10T20:10:23.000Z - 3 months ago

Brainsway management to meet virtually with Northland

Brainsway price target raised to $30 from $24 at H.C. Wainwright

2026-01-26T11:11:37.000Z - 4 months ago

Brainsway price target raised to $30 from $24 at H.C. Wainwright

Brainsway price target raised to $30 from $23 at Northland

2026-01-22T14:06:50.000Z - 4 months ago

Brainsway price target raised to $30 from $23 at Northland

Brainsway announces draft coverage policy from Highmark for Deep TMS

2026-01-21T12:41:05.000Z - 4 months ago

Brainsway announces draft coverage policy from Highmark for Deep TMS

BrainsWay Announces Draft Coverage Policy from Highmark® for Accelerated Deep TMS™

Jan 21, 2026, 7:30 AM EST - 4 months ago

BrainsWay Announces Draft Coverage Policy from Highmark® for Accelerated Deep TMS™

Brainsway announces U.S. FDA granted PMA for Neurolief’s ProlivRx system

2026-01-12T12:47:01.000Z - 4 months ago

Brainsway announces U.S. FDA granted PMA for Neurolief’s ProlivRx system

BrainsWay Announces FDA Approval of Neurolief's Proliv™Rx Neuromodulation System for Major Depressive Disorder (MDD)

Jan 12, 2026, 7:30 AM EST - 4 months ago

BrainsWay Announces FDA Approval of Neurolief's Proliv™Rx Neuromodulation System for Major Depressive Disorder (MDD)

Brainsway announces first coverage policy for accelerated Deep TMS

2026-01-07T12:37:11.000Z - 5 months ago

Brainsway announces first coverage policy for accelerated Deep TMS

BrainsWay Announces First Coverage Policy for Accelerated Deep TMS™

Jan 7, 2026, 7:30 AM EST - 5 months ago

BrainsWay Announces First Coverage Policy for Accelerated Deep TMS™

Brainsway announces Optum Behavioral expanded policy applicable to Deep TMS

2025-12-22T12:35:31.000Z - 5 months ago

Brainsway announces Optum Behavioral expanded policy applicable to Deep TMS

UNH

BrainsWay Reports Expansion of Adolescent Depression Coverage Applicable to Deep TMS™

Dec 22, 2025, 7:30 AM EST - 5 months ago

BrainsWay Reports Expansion of Adolescent Depression Coverage Applicable to Deep TMS™

Brainsway price target raised to $24 from $18 at H.C. Wainwright

2025-12-08T11:21:38.000Z - 6 months ago

Brainsway price target raised to $24 from $18 at H.C. Wainwright

BrainsWay Transcript: Analyst & Investor Day 2025

Dec 1, 2025, 10:00 AM EST - 6 months ago

BrainsWay Transcript: Analyst & Investor Day 2025

BrainsWay Press release: FY 2025

Dec 1, 2025, 10:00 AM EST - 6 months ago

BrainsWay Press release: FY 2025

BrainsWay to Host Virtual Analyst & Investor Day to Discuss the Company's Growth Strategy and Deep TMS™ Treatment December 1, 2025

Nov 25, 2025, 7:30 AM EST - 6 months ago

BrainsWay to Host Virtual Analyst & Investor Day to Discuss the Company's Growth Strategy and Deep TMS™ Treatment December 1, 2025

BrainsWay Launches First Clinical Trial of Deep TMS 360™ System for Alcohol Use Disorder

Nov 17, 2025, 7:30 AM EST - 6 months ago

BrainsWay Launches First Clinical Trial of Deep TMS 360™ System for Alcohol Use Disorder

BrainsWay Receives FDA Clearance of Deep TMS™ as Adjunct Therapy for Major Depressive Disorder (MDD) in Adolescents Aged 15 to 21

Nov 13, 2025, 6:00 AM EST - 7 months ago

BrainsWay Receives FDA Clearance of Deep TMS™ as Adjunct Therapy for Major Depressive Disorder (MDD) in Adolescents Aged 15 to 21

BrainsWay Slides: Investor Presentation

Nov 12, 2025, 7:00 AM EST - 7 months ago

BrainsWay Slides: Investor Presentation

BrainsWay Earnings Call Transcript: Q3 2025

Nov 11, 2025, 8:30 AM EST - 7 months ago

BrainsWay Earnings Call Transcript: Q3 2025

BrainsWay Earnings release: Q3 2025

Nov 11, 2025, 8:30 AM EST - 7 months ago

BrainsWay Earnings release: Q3 2025

BrainsWay Reports Third Quarter 2025 Financial Results and Operational Highlights

Nov 11, 2025, 7:30 AM EST - 7 months ago

BrainsWay Reports Third Quarter 2025 Financial Results and Operational Highlights

BrainsWay Reports National Institutes of Health Grant to Leading U.S. Research Team Investigating Accelerated Deep TMS for Treatment of Alcohol Use Disorder

Nov 4, 2025, 8:00 AM EST - 7 months ago

BrainsWay Reports National Institutes of Health Grant to Leading U.S. Research Team Investigating Accelerated Deep TMS for Treatment of Alcohol Use Disorder

BrainsWay to Report Third Quarter 2025 Financial Results on November 11, 2025

Oct 28, 2025, 8:00 AM EDT - 7 months ago

BrainsWay to Report Third Quarter 2025 Financial Results on November 11, 2025

BrainsWay Announces Additional Minority-Stake Investments in Leading U.S. Mental Health Providers

Oct 27, 2025, 7:30 AM EDT - 7 months ago

BrainsWay Announces Additional Minority-Stake Investments in Leading U.S. Mental Health Providers

BrainsWay Targets Expansion of its Total Addressable Market through a Strategic Investment in Neuromodulation Systems Developer, Neurolief Ltd.

Aug 21, 2025, 7:30 AM EDT - 10 months ago

BrainsWay Targets Expansion of its Total Addressable Market through a Strategic Investment in Neuromodulation Systems Developer, Neurolief Ltd.

BrainsWay Acquires Minority-Stake in Axis Integrated Mental Health

Aug 20, 2025, 7:30 AM EDT - 10 months ago

BrainsWay Acquires Minority-Stake in Axis Integrated Mental Health

BrainsWay Earnings Call Transcript: Q2 2025

Aug 13, 2025, 8:00 AM EDT - 10 months ago

BrainsWay Earnings Call Transcript: Q2 2025

BrainsWay Earnings release: Q2 2025

Aug 13, 2025, 8:00 AM EDT - 10 months ago

BrainsWay Earnings release: Q2 2025

BrainsWay Reports Second Quarter 2025 Financial Results and Operational Highlights

Aug 13, 2025, 7:30 AM EDT - 10 months ago

BrainsWay Reports Second Quarter 2025 Financial Results and Operational Highlights

BrainsWay Reports Positive Results from Multicenter Randomized Study of Accelerated Deep TMS for Major Depressive Disorder (MDD)

Jun 11, 2025, 7:30 AM EDT - 1 year ago

BrainsWay Reports Positive Results from Multicenter Randomized Study of Accelerated Deep TMS for Major Depressive Disorder (MDD)

BrainsWay Announces Gold Sponsorship at the 2025 Clinical TMS Society Annual Meeting in San Diego

Jun 10, 2025, 8:00 AM EDT - 1 year ago

BrainsWay Announces Gold Sponsorship at the 2025 Clinical TMS Society Annual Meeting in San Diego

BrainsWay Announces $5 Million Minority-Stake Investment in Stella MSO, LLC

Jun 4, 2025, 7:30 AM EDT - 1 year ago

BrainsWay Announces $5 Million Minority-Stake Investment in Stella MSO, LLC

BrainsWay Earnings Call Transcript: Q1 2025

May 13, 2025, 8:30 AM EDT - 1 year ago

BrainsWay Earnings Call Transcript: Q1 2025

BrainsWay Earnings release: Q1 2025

May 13, 2025, 8:30 AM EDT - 1 year ago

BrainsWay Earnings release: Q1 2025

BrainsWay Reports First Quarter 2025 Financial Results and Operational Highlights

May 13, 2025, 7:30 AM EDT - 1 year ago

BrainsWay Reports First Quarter 2025 Financial Results and Operational Highlights

BrainsWay Registration statement: Registration Filing

Apr 22, 2025, 8:00 AM EDT - 1 year ago

BrainsWay Registration statement: Registration Filing

BrainsWay Earnings Call Transcript: Q4 2024

Mar 11, 2025, 8:30 AM EDT - 1 year ago

BrainsWay Earnings Call Transcript: Q4 2024

BrainsWay Annual report: Q4 2024

Mar 11, 2025, 8:30 AM EDT - 1 year ago

BrainsWay Annual report: Q4 2024

BrainsWay Earnings release: Q4 2024

Mar 11, 2025, 8:30 AM EDT - 1 year ago

BrainsWay Earnings release: Q4 2024

BrainsWay Reports Fourth Quarter and Full Year 2024 Financial Results and Operational Highlights

Mar 11, 2025, 7:30 AM EDT - 1 year ago

BrainsWay Reports Fourth Quarter and Full Year 2024 Financial Results and Operational Highlights

BrainsWay Reports Positive Independent Pilot Data on Accelerated Deep TMS Treatment of Alcohol Use Disorder

Dec 12, 2024, 8:00 AM EST - 1 year ago

BrainsWay Reports Positive Independent Pilot Data on Accelerated Deep TMS Treatment of Alcohol Use Disorder

BrainsWay Reports Promising Feasibility Data Showing Pain Reduction with Deep TMS Therapy

Nov 20, 2024, 8:00 AM EST - 1 year ago

BrainsWay Reports Promising Feasibility Data Showing Pain Reduction with Deep TMS Therapy

BrainsWay Earnings Call Transcript: Q3 2024

Nov 12, 2024, 8:30 AM EST - 1 year ago

BrainsWay Earnings Call Transcript: Q3 2024

BrainsWay Earnings release: Q3 2024

Nov 12, 2024, 8:30 AM EST - 1 year ago

BrainsWay Earnings release: Q3 2024

BrainsWay Reports Third Quarter 2024 Financial Results and Operational Highlights

Nov 12, 2024, 7:30 AM EST - 1 year ago

BrainsWay Reports Third Quarter 2024 Financial Results and Operational Highlights

BrainsWay to Report Third Quarter 2024 Financial Results On November 12, 2024

Oct 29, 2024, 8:00 AM EDT - 1 year ago

BrainsWay to Report Third Quarter 2024 Financial Results On November 12, 2024

BrainsWay Further Penetrates East Asia with Placement of 15 Additional Deep TMS™ Systems in Taiwan and South Korea

Oct 9, 2024, 7:30 AM EDT - 1 year ago

BrainsWay Further Penetrates East Asia with Placement of 15 Additional Deep TMS™ Systems in Taiwan and South Korea

BrainsWay Announces US$20 Million Private Placement with Valor Equity Partners

Sep 30, 2024, 7:30 AM EDT - 1 year ago

BrainsWay Announces US$20 Million Private Placement with Valor Equity Partners

BrainsWay Announces Significant Expansion on U.S. East Coast

Sep 16, 2024, 7:30 AM EDT - 1 year ago

BrainsWay Announces Significant Expansion on U.S. East Coast

Israel Ministry of Defense Clears BrainsWay Deep TMS™ for PTSD Reimbursement at Israeli Hospitals

Sep 10, 2024, 8:00 AM EDT - 1 year ago

Israel Ministry of Defense Clears BrainsWay Deep TMS™ for PTSD Reimbursement at Israeli Hospitals

BrainsWay Appoints Richard A. Bermudes, M.D.

Aug 29, 2024, 7:30 AM EDT - 1 year ago

BrainsWay Appoints Richard A. Bermudes, M.D.

BrainsWay Earnings Call Transcript: Q2 2024

Aug 6, 2024, 8:30 AM EDT - 1 year ago

BrainsWay Earnings Call Transcript: Q2 2024

BrainsWay Earnings release: Q2 2024

Aug 6, 2024, 8:30 AM EDT - 1 year ago

BrainsWay Earnings release: Q2 2024

BrainsWay Reports Second Quarter 2024 Financial Results and Operational Highlights

Aug 6, 2024, 7:30 AM EDT - 1 year ago

BrainsWay Reports Second Quarter 2024 Financial Results and Operational Highlights

BrainsWay to Report Second Quarter 2024 Financial Results on August 6, 2024

Jul 23, 2024, 8:00 AM EDT - 2 years ago

BrainsWay to Report Second Quarter 2024 Financial Results on August 6, 2024

BrainsWay Registration statement: Registration Filing

Jul 22, 2024, 8:00 AM EDT - 2 years ago

BrainsWay Registration statement: Registration Filing

BrainsWay Expands Global Imprint with Exclusive Multi-Year Distribution Agreement in Canada

Jun 17, 2024, 7:30 AM EDT - 2 years ago

BrainsWay Expands Global Imprint with Exclusive Multi-Year Distribution Agreement in Canada

BrainsWay Launches Prospective, Randomized, Controlled, Multicenter Trial Evaluating Accelerated Deep TMS™ for Depression

Jun 10, 2024, 7:30 AM EDT - 2 years ago

BrainsWay Launches Prospective, Randomized, Controlled, Multicenter Trial Evaluating Accelerated Deep TMS™ for Depression

BrainsWay Receives Expanded FDA Labeling to Treat Late Life Depression

Jun 3, 2024, 7:30 AM EDT - 2 years ago

BrainsWay Receives Expanded FDA Labeling to Treat Late Life Depression

BrainsWay Earnings Call Transcript: Q1 2024

May 8, 2024, 8:30 AM EDT - 2 years ago

BrainsWay Earnings Call Transcript: Q1 2024

BrainsWay Earnings release: Q1 2024

May 8, 2024, 8:30 AM EDT - 2 years ago

BrainsWay Earnings release: Q1 2024

BrainsWay Reports First Quarter 2024 Financial Results and Operational Highlights

May 8, 2024, 7:30 AM EDT - 2 years ago

BrainsWay Reports First Quarter 2024 Financial Results and Operational Highlights

BrainsWay to Report First Quarter 2024 Financial Results on May 8, 2024

Apr 24, 2024, 8:00 AM EDT - 2 years ago

BrainsWay to Report First Quarter 2024 Financial Results on May 8, 2024

BrainsWay Announces Published Review Results Highlighting Potential of Deep TMS™ to Treat Parkinson's Disease

Apr 4, 2024, 8:00 AM EDT - 2 years ago

BrainsWay Announces Published Review Results Highlighting Potential of Deep TMS™ to Treat Parkinson's Disease

BrainsWay Broadens Partnership with Katie's Way Plus Through Order of an Additional 18 Deep TMS™ Systems

Mar 18, 2024, 7:30 AM EDT - 2 years ago

BrainsWay Broadens Partnership with Katie's Way Plus Through Order of an Additional 18 Deep TMS™ Systems

DARKP00L
DARKP00L May. 26 at 11:26 AM
$BWAY 06:41 on May. 26 2026 HC Wainwright & Co. Maintains Buy on BrainsWay, Raises Price Target to $17 #tradeideas
0 · Reply
Estimize
Estimize May. 14 at 10:03 AM
Wall St is expecting 0.04 EPS for $BWAY Q2 [Reporting 08/12 BMO] http://www.estimize.com/intro/bway?chart=historical&metric_name=eps&utm_co
0 · Reply
MarketBeat
MarketBeat May. 13 at 2:07 PM
https://marketbeat.com/a/8652620/ $BWAY Brainsway Q1 Earnings Call Highlights
0 · Reply
EarningsInsider
EarningsInsider May. 13 at 1:31 PM
https://www.marketbeat.com/earnings/reports/2026-5-13-brainsway-ltd-stock/ $BWAY Brainsway Earnings Transcript
0 · Reply
DARKP00L
DARKP00L May. 13 at 12:03 PM
$BWAY 07:34 on May. 13 2026 BrainsWay Affirms FY2026 Sales Guidance of $66.000M-$68.000M vs $66.350M Est #tradeideas
0 · Reply
StocktwitsEarnings
StocktwitsEarnings May. 13 at 11:38 AM
$BWAY Q1 '26 Earnings Results & Recap • Reported GAAP EPS of $0.06 up 100.00% YoY • Reported revenue of $15.53M up 34.63% YoY • BrainsWay reiterates full-year 2026 revenue guidance of $66M to $68M, targeting operating income of 13%-14% and Adjusted EBITDA of $12M to $14M, representing significant growth over 2025.
0 · Reply
SuperGreenToday
SuperGreenToday May. 12 at 7:50 PM
$BWAY Share Price: $16.79 Contract Selected: Oct 16, 2026 $20 Calls Buy Zone: $0.04 – $0.05 Target Zone: $0.07 – $0.09 Potential Upside: 60% ROI Time to Expiration: 156 Days | Updates via https://fxcapta.com/stockinfo/
0 · Reply
evparty
evparty May. 12 at 7:41 PM
$BWAY ISRAELI 🇮🇱MEDICAL DEVICE COMPANY CLINICS ADMINISTERING THIS ARE MAKING MONEY HAND OVER FIST EARNINGS TOMORROW PREMARKET 💰💰💰💰 $TSLA $WEN $SPY
0 · Reply
Blahblahstock25
Blahblahstock25 Apr. 24 at 7:31 PM
$BWAY https://www.marketbeat.com/instant-alerts/brainsway-nasdaqbway-sets-new-12-month-high-should-you-buy-2026-04-24/ The literally make a machine that cures depression. This will only go up for the foreseeable future
0 · Reply
moonlife224
moonlife224 Apr. 16 at 7:56 PM
$AEHL $BWAY $SPRC $TR
0 · Reply
AtlasAnalysis
AtlasAnalysis Apr. 16 at 1:43 PM
$BWAY another new year high coming?
0 · Reply
OfficialStocktwitsUser
OfficialStocktwitsUser Apr. 16 at 12:43 AM
$BWAY RSI: 62.91, MACD: 0.5254 Vol: 0.81, MA20: 13.66, MA50: 12.77 🟢 BUY - Uptrend + healthy RSI 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.
0 · Reply
focafoca99
focafoca99 Apr. 13 at 3:39 PM
$BWAY is announcing participation in the Needham Virtual Healthcare Conference on April 15.
0 · Reply
Doozio
Doozio Apr. 10 at 1:20 AM
$NBIS da huckleberries are going thru da $$$ for this 🧠leader🐑 as da under da radar 💎 $BWAY bust outta $ASND ing bases 🐒🍌🧠⏰♾️
3 · Reply
Doozio
Doozio Apr. 4 at 6:04 PM
$BWAY even stonk splits won’t stop da 🧠 way back to da east side! 🐒🍌🧠⏰♾️. Powerful 👀
0 · Reply
Bazzzigar
Bazzzigar Mar. 26 at 7:00 PM
$BWAY BBNX
0 · Reply
DARKP00L
DARKP00L Mar. 26 at 11:37 AM
$BWAY 07:37 on Mar. 26 2026 BrainsWay Completes Additional $6M Milestone-Based Convertible Loan To Neurolief #tradeideas
0 · Reply
topstockalerts
topstockalerts Mar. 11 at 5:27 PM
$BWAY What’s your upside target here? Momentum continues to favor the bulls 🐂. This trend has legs.
0 · Reply
AStrokeOfLuck
AStrokeOfLuck Mar. 11 at 5:26 PM
$BWAY didn't know this was a treatment option for some
0 · Reply
mikesterz7
mikesterz7 Mar. 11 at 12:31 PM
$BWAY 🚨 Full‑year revenue +27% to $52.2M Q4 adjusted EBITDA +53% to $2.3M Remaining performance obligations +43% to ~$70M 2026 guidance targets revenue $66–68M (27%–30% growth) and adjusted EBITDA $12–14M FDA label expansion and insurer coverage supporting commercial adoption
0 · Reply
topstockalerts
topstockalerts Mar. 11 at 12:10 PM
$BWAY Is it going higher? Comment below..
0 · Reply